WailooK. Drawing blood: technology and disease identity in Twentieth-century America. Baltimore: Johns Hopkins University Press, 1999.
2.
RowleyJD. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature1973;243:290–3.doi:10.1038/243290a0
3.
MeloJV. The molecular biology of chronic myeloid leukaemia. Leukemia1996;10:751–6.
4.
KurzrockR, KantarjianHM, DrukerBJ, . Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics. Ann Intern Med2003;138:819–30.doi:10.7326/0003-4819-138-10-200305200-00010
5.
HicksEB, RappaportH, WinterWJ. Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer1956;9:792–821.doi:10.1002/1097-0142(195607/08)9:4<792::aid-cncr2820090429>3.0.co;2-b
6.
LennertK, CollinsRD, LukesRJ. Concordance of the Kiel and Lukes-Collins classifications of non-Hodgkin's lymphomas. Histopathology1983;7:549–59.doi:10.1111/j.1365-2559.1983.tb02267.x
7.
LukesRJ, CollinsRD. Immunologic characterization of human malignant lymphomas. Cancer1974;34:1488–503.doi:10.1002/1097-0142(197410)34:8+<1488::AID-CNCR2820340822>3.0.CO;2-C
8.
SwerdlowSH, CookJR. As the world turns, evolving lymphoma classifications–past, present and future. Hum Pathol2019;S0046-8177:30159–5.doi:10.1016/j.humpath.2019.08.019
9.
WalewskiJ. Aggressive B-cell lymphoma: chasing the target. J Investig Med2020;68:331–4.
10.
SchmitzR, WrightGW, HuangDW, . Genetics and pathogenesis of diffuse large B-cell lymphoma. N Engl J Med2018;378:1396–407.doi:10.1056/NEJMoa1801445
11.
ChapuyB, StewartC, DunfordAJ, . Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med2018;24:679–90.doi:10.1038/s41591-018-0016-8
